Chargement en cours...

Lamivudine for preventing reactivation of hepatitis B infection in patients planned to undergo immunosuppressive therapy

This is a protocol for a Cochrane Review (Intervention). The objectives are as follows: To evaluate the beneficial and harmful effects of lamivudine in preventing reactivation of HBV during or following immunosuppressive therapy in HBsAg‐positive patients. To estimate the optimal time of initiating...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Cochrane Database Syst Rev
Auteurs principaux: Katz, Lior H, Fraser, Abigail, Leibovici, Leonard, Tur‐Kaspa, Ran, Goldvaser, Hadar
Format: Artigo
Langue:Inglês
Publié: John Wiley & Sons, Ltd 2019
Sujets:
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC6741844/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD005264.pub3
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!